Utilisation, expenditure, and treatment patterns associated with calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) reimbursed subject to a managed access protocol in Ireland.
This study presents data on utilisation, expenditure and treatment patterns with CGRP mAbs available under a managed access protocol in Ireland, to a cohort of treatment refractory patients (failed three or more previous treatments) with chronic migraine.
Source: Value in Health - Category: International Medicine & Public Health Authors: Amelia Smith, Karen Finnigan, Sarah Clarke, Michael Barry, Claire Gorry Source Type: research
More News: Expenditures | Genetics | Headache | International Medicine & Public Health | Ireland Health | Migraine | Study